{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T23:45:46Z","timestamp":1787960746579,"version":"build-2784847793"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013699","name":"The Ohio State University OSUCCC - James","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013699","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006928","name":"Ohio State University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006928","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000051","name":"National Human Genome Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000051","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"NIH NCI","doi-asserted-by":"publisher","award":["R01CA188228"],"award-info":[{"award-number":["R01CA188228"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"NIH NCI","doi-asserted-by":"publisher","award":["UG1CA233331"],"award-info":[{"award-number":["UG1CA233331"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.canlet.2026.218325","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T16:25:57Z","timestamp":1771604757000},"page":"218325","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Endogenous inhibitors of PP2A activate oncogenic and DNA damage response kinases in glioblastoma"],"prefix":"10.1016","volume":"645","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3385-1947","authenticated-orcid":false,"given":"John Ryan","family":"Jacob","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahid M.","family":"Nimjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Bradley","family":"Elder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnab","family":"Chakravarti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3216-7812","authenticated-orcid":false,"given":"Kamalakannan","family":"Palanichamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2026.218325_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-pathol-011110-130324","article-title":"Glioblastoma: from molecular pathology to targeted treatment","volume":"9","author":"Cloughesy","year":"2014","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.canlet.2026.218325_bib2","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/nature07385","article-title":"Comprehensive genomic characterization defines human glioblastoma genes and core pathways","volume":"455","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218325_bib3","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.ccell.2016.03.012","article-title":"Single-cell phosphoproteomics resolves adaptive signaling dynamics and informs targeted combination therapy in glioblastoma","volume":"29","author":"Wei","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218325_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22041831","article-title":"Receptor tyrosine kinase signaling and targeting in glioblastoma multiforme","volume":"22","author":"Tilak","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2026.218325_bib5","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1073\/pnas.1114033109","article-title":"Intratumoral heterogeneity of receptor tyrosine kinases EGFR and PDGFRA amplification in glioblastoma defines subpopulations with distinct growth factor response","volume":"109","author":"Szerlip","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2026.218325_bib6","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1126\/science.1142946","article-title":"Coactivation of receptor tyrosine kinases affects the response of tumor cells to targeted therapies","volume":"318","author":"Stommel","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.canlet.2026.218325_bib7","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/nature07385","article-title":"Comprehensive genomic characterization defines human glioblastoma genes and core pathways","volume":"455","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218325_bib8","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1158\/2159-8290.CD-12-0502","article-title":"De-repression of PDGFR\u03b2 transcription promotes acquired resistance to EGFR tyrosine kinase inhibitors in glioblastoma patients","volume":"3","author":"Akhavan","year":"2013","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2026.218325_bib9","doi-asserted-by":"crossref","first-page":"e229","DOI":"10.1016\/S1470-2045(12)70558-2","article-title":"Protein phosphatase 2A: a target for anticancer therapy","volume":"14","author":"Perrotti","year":"2013","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.canlet.2026.218325_bib10","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.cell.2006.11.033","article-title":"Structure of the protein phosphatase 2A holoenzyme","volume":"127","author":"Xu","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2026.218325_bib11","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1126\/science.282.5387.284","article-title":"Alterations of the PPP2R1B gene in human lung and colon cancer","volume":"282","author":"Wang","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.canlet.2026.218325_bib12","doi-asserted-by":"crossref","first-page":"4242","DOI":"10.1158\/0008-5472.CAN-19-0218","article-title":"The highly recurrent PP2A aalpha-subunit mutation P179R alters protein structure and impairs PP2A enzyme function to promote endometrial tumorigenesis","volume":"79","author":"Taylor","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2026.218325_bib13","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1021\/bi00006a020","article-title":"Purification and characterization of two potent heat-stable protein inhibitors of protein phosphatase 2A from bovine kidney","volume":"34","author":"Li","year":"1995","journal-title":"Biochemistry"},{"key":"10.1016\/j.canlet.2026.218325_bib14","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cell.2007.04.044","article-title":"CIP2A inhibits PP2A in human malignancies","volume":"130","author":"Junttila","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2026.218325_bib15","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1042\/BST20160161","article-title":"Regulation of protein phosphatase 2A (PP2A) tumor suppressor function by PME-1","volume":"44","author":"Kaur","year":"2016","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.canlet.2026.218325_bib16","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.3389\/fphar.2018.01477","article-title":"A guide to PIN1 function and mutations across cancers","volume":"9","author":"El Boustani","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.canlet.2026.218325_bib17","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3389\/fcell.2018.00162","article-title":"The oncogenic functions of MASTL kinase","volume":"6","author":"Marzec","year":"2018","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.canlet.2026.218325_bib18","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1091\/mbc.12.1.185","article-title":"Methylation of the protein phosphatase 2A catalytic subunit is essential for association of Balpha regulatory subunit but not SG2NA, striatin, or polyomavirus middle tumor antigen","volume":"12","author":"Yu","year":"2001","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.canlet.2026.218325_bib19","doi-asserted-by":"crossref","first-page":"14382","DOI":"10.1074\/jbc.274.20.14382","article-title":"A protein phosphatase methylesterase (PME-1) is one of several novel proteins stably associating with two inactive mutants of protein phosphatase 2A","volume":"274","author":"Ogris","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2026.218325_bib20","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aax6490","article-title":"Antibodies recognizing the C terminus of PP2A catalytic subunit are unsuitable for evaluating PP2A activity and holoenzyme composition","volume":"13","author":"Frohner","year":"2020","journal-title":"Sci. Signal."},{"key":"10.1016\/j.canlet.2026.218325_bib21","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.molcel.2009.09.025","article-title":"Alpha4 is an essential regulator of PP2A phosphatase activity","volume":"36","author":"Kong","year":"2009","journal-title":"Mol. Cell"},{"key":"10.1016\/j.canlet.2026.218325_bib22","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.cmet.2013.04.013","article-title":"EGFR mutation-induced alternative splicing of max contributes to growth of glycolytic tumors in brain cancer","volume":"17","author":"Babic","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.canlet.2026.218325_bib23","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.cmet.2013.09.013","article-title":"mTOR complex 2 controls glycolytic metabolism in glioblastoma through FoxO acetylation and upregulation of c-Myc","volume":"18","author":"Masui","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.canlet.2026.218325_bib24","doi-asserted-by":"crossref","first-page":"5774","DOI":"10.1038\/sj.onc.1206677","article-title":"P53 and radiation responses","volume":"22","author":"Fei","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2026.218325_bib25","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1158\/1078-0432.CCR-12-3408","article-title":"ATM kinase inhibition preferentially sensitizes p53-mutant glioma to ionizing radiation","volume":"19","author":"Biddlestone-Thorpe","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218325_bib26","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1158\/2159-8290.CD-12-0292","article-title":"Senescence sensitivity of breast cancer cells is defined by positive feedback loop between CIP2A and E2F1","volume":"3","author":"Laine","year":"2013","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2026.218325_bib27","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1158\/1535-7163.MCT-17-0429","article-title":"Lack of constitutively active DNA repair sensitizes glioblastomas to akt inhibition and induces synthetic lethality with radiation treatment in a p53-Dependent manner","volume":"17","author":"Palanichamy","year":"2018","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.canlet.2026.218325_bib28","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1111\/jcmm.13639","article-title":"PHAP1 promotes glioma cell proliferation by regulating the Akt\/p27\/stathmin pathway","volume":"22","author":"Xie","year":"2018","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.canlet.2026.218325_bib29","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1038\/onc.2010.622","article-title":"Targeting SET\/I(2)PP2A oncoprotein functions as a multi-pathway strategy for cancer therapy","volume":"30","author":"Switzer","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2026.218325_bib30","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3732\/ajb.1600380","article-title":"Physiological effects of temperature do not explain prevalence of females in populations of gynodioecious Lobelia siphilitica growing in warmer climates","volume":"104","author":"Bailey","year":"2017","journal-title":"Am. J. Bot."},{"key":"10.1016\/j.canlet.2026.218325_bib31","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s11010-011-1158-x","article-title":"Accumulation of the SET protein in HEK293T cells and mild oxidative stress: cell survival or death signaling","volume":"363","author":"Leopoldino","year":"2012","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.canlet.2026.218325_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.105584","article-title":"PP2A inhibitor SET promotes mTORC1 and Bmi1 signaling through Akt activation and maintains the colony-formation ability of cancer cells","volume":"300","author":"Kohyanagi","year":"2024","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2026.218325_bib33","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1158\/1535-7163.MCT-08-0680","article-title":"Inhibition of Akt inhibits growth of glioblastoma and glioblastoma stem-like cells","volume":"8","author":"Gallia","year":"2009","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.canlet.2026.218325_bib34","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1038\/onc.2013.198","article-title":"EGFRvIII stimulates glioma growth and invasion through PKA-dependent serine phosphorylation of Dock180","volume":"33","author":"Feng","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2026.218325_bib35","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/cbf.3518","article-title":"STAT1 determines aggressiveness of glioblastoma both in vivo and in vitro through wnt\/\u03b2-catenin signalling pathway","volume":"38","author":"Zhao","year":"2020","journal-title":"Cell Biochem. Funct."},{"key":"10.1016\/j.canlet.2026.218325_bib36","doi-asserted-by":"crossref","first-page":"909","DOI":"10.3171\/jns.2002.96.5.0909","article-title":"Aberrant nuclear factor-kappaB activity and its participation in the growth of human malignant astrocytoma","volume":"96","author":"Nagai","year":"2002","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.canlet.2026.218325_bib37","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11060-007-9390-7","article-title":"Aberrant constitutive activation of nuclear factor kappaB in glioblastoma multiforme drives invasive phenotype","volume":"85","author":"Raychaudhuri","year":"2007","journal-title":"J. Neuro Oncol."},{"key":"10.1016\/j.canlet.2026.218325_bib38","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ccr.2013.08.001","article-title":"Mesenchymal differentiation mediated by NF-\u03baB promotes radiation resistance in glioblastoma","volume":"24","author":"Bhat","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218325_bib39","first-page":"352","article-title":"Metadherin\/astrocyte elevated gene-1 positively regulates the stability and function of forkhead box M1 during tumorigenesis","volume":"19","author":"Yang","year":"2017","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.canlet.2026.218325_bib40","doi-asserted-by":"crossref","first-page":"12414","DOI":"10.1073\/pnas.1220674110","article-title":"Dissection of TBK1 signaling via phosphoproteomics in lung cancer cells","volume":"110","author":"Kim","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2026.218325_bib41","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1158\/1541-7786.MCR-19-0934","article-title":"Constitutive CHK1 expression drives a pSTAT3-CIP2A circuit that promotes glioblastoma cell survival and growth","volume":"18","author":"Khanna","year":"2020","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218325_bib42","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aar8426","article-title":"ANP32A regulates ATM expression and prevents oxidative stress in cartilage, brain, and bone","volume":"10","author":"Cornelis","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.canlet.2026.218325_bib43","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1158\/1535-7163.MCT-14-0614","article-title":"Protein phosphatase 2A inhibition with LB100 enhances radiation-induced mitotic catastrophe and tumor growth delay in glioblastoma","volume":"14","author":"Gordon","year":"2015","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.canlet.2026.218325_bib44","doi-asserted-by":"crossref","first-page":"4422","DOI":"10.1158\/1078-0432.CCR-13-0788","article-title":"Inhibition of protein phosphatase 2A radiosensitizes pancreatic cancers by modulating CDC25C\/CDK1 and homologous recombination repair","volume":"19","author":"Wei","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218325_bib45","doi-asserted-by":"crossref","first-page":"11697","DOI":"10.1073\/pnas.0905930106","article-title":"Inhibition of serine\/threonine phosphatase PP2A enhances cancer chemotherapy by blocking DNA damage induced defense mechanisms","volume":"106","author":"Lu","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2026.218325_bib46","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0092-8674(01)00309-9","article-title":"Artemis, a novel DNA double-strand break repair\/V(D)J recombination protein, is mutated in human severe combined immune deficiency","volume":"105","author":"Moshous","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2026.218325_bib47","first-page":"557","article-title":"Radiation reaction in ataxia telangiectasia","volume":"116","author":"Morgan","year":"1968","journal-title":"Am. J. Dis. Child."},{"key":"10.1016\/j.canlet.2026.218325_bib48","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1126\/science.1065521","article-title":"ATR and ATRIP: partners in checkpoint signaling","volume":"294","author":"Cortez","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.canlet.2026.218325_bib49","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1158\/0008-5472.CAN-08-2760","article-title":"PME-1 protects extracellular signal-regulated kinase pathway activity from protein phosphatase 2A-mediated inactivation in human malignant glioma","volume":"69","author":"Puustinen","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2026.218325_bib50","doi-asserted-by":"crossref","first-page":"7001","DOI":"10.1158\/0008-5472.CAN-16-1134","article-title":"PP2A inhibitor PME-1 drives kinase inhibitor resistance in glioma cells","volume":"76","author":"Kaur","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2026.218325_bib51","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1002\/1878-0261.13488","article-title":"PP2A-based triple-strike therapy overcomes mitochondrial apoptosis resistance in brain cancer cells","volume":"17","author":"Denisova","year":"2023","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.canlet.2026.218325_bib52","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1158\/0008-5472.CAN-22-3382","article-title":"PP2Ac deficiency enhances tumor immunogenicity by activating STING-type I interferon signaling in glioblastoma","volume":"83","author":"Mondal","year":"2023","journal-title":"Cancer Res."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526000881?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526000881?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T03:59:59Z","timestamp":1779076799000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383526000881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":52,"alternative-id":["S0304383526000881"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218325","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endogenous inhibitors of PP2A activate oncogenic and DNA damage response kinases in glioblastoma","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218325","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"218325"}}